Karbonhidrat Metabolizması Bozuklukları ve Glikojen Depo Hastalıkları
Özet
Organik asidemiler, aminoasit ve yağ asidi metabolizmasındaki enzim eksikliklerine bağlı olarak ortaya çıkan ve multisistemik hasara yol açabilen nadir metabolik hastalıklar grubudur. Erken dönemde beslenememe, asidoz ve nörolojik bulgularla kendini gösteren bu hastalıkların tanısında idrar ve kan analizleri ile genetik testler belirleyici rol oynar. Tedavi sürecinde özel diyet programları, karnitin desteği ve metabolik krizleri yönetmeye yönelik agresif destekler hayati öneme sahiptir. Erken tanı ve doğru yönetim, geri dönüşümsüz nörolojik hasarı önlemek için kritik bir gerekliliktir.
Organic acidemias are a group of rare metabolic disorders arising from enzymatic defects in amino acid and fatty acid pathways, leading to multisystemic impairment. Characterized by early-onset symptoms such as poor feeding, acidosis, and neurological distress, these conditions are diagnosed through specific biochemical analysis and genetic testing. Management requires strict dietary interventions, metabolic support, and aggressive crisis treatment to mitigate toxic metabolite accumulation. Prompt diagnosis and intervention are essential to preventing irreversible neurological damage and improving patient outcomes.
Referanslar
Saudubray JM, Baumgartner MR, Walter J Eds. Inborn Metabolic Diseases Diagnosis and Treatment. 6th Edition. Berlin, Heidelberg; Springer; 2016. p. 277-294.
Kliegman RM, Stanton BF, St Geme JW, Schor NF, Behrman RE. Nelson Textbook of Pediatrics. 20th Edition. Philadelphia; Elsevier; 2016. p. 649-684.
Amanvermez R, Avcı B. Marks Tıbbi Biyokimyanın Esasları Klinik Yaklaşım. İkinci baskı. İstanbul:İstanbul Medikal Sağlık ve Yayıncılık Hiz. Tic. Ltd. Şti.;2017. p. 525-527.
Simon E, Wendel U, Schadewaldt P. Maple syrup urine disease-treatment and outcome in patients of Turkish descent in Germany. The Turkish Journal of Pediatrics. 2005; 47: 8-13.
Schillaci LAP, DeBrosse SD, McCandless SE. Inborn Errors of Metabolism with Acidosis. Pediatr Clin N Am. 2018; 65:209-230.
Çoşkun T, Yurdakök M. Yenidoğanda Kalıtsal Metabolik Hastalıklar.Ankara; Güneş Tıp Kitapevleri Ltd. Şti.;2014. p.97-102.
Fraser JL, Venditti CP. Methylmalonic and Propionic Acidemias: Clinical Management Update. Curr Opin Pediatr. 2016 December; 28(6):682-693.
Tanacan A, Gurbuz BB, Aydın E, Erden M, Coskun T, Beksac MS. Prenatal diagnosis of organic asidemias at a tertiary center. BJMG. 2019; 22 (1):29-34.
Aldubayan SH, Rodan LH, Berry GT, Levy HL. Acute Illness Protocol for Organic Acidemias. Pediatr Emer Care. 2017; 33:142-146.
Aygun F, Varol F, Aktuglu CZ, Kıykım E, Cam H. Continuous Renal Replacement Therapy with High Flow Rate Can Effectively, Safely and Quickly Reduce Plasma Ammonia and Leucine Levels in Children.
Ghai SJ, Joffe AR, Bond GY, Siriwardena K, Chan A et al. Pre-school neurocognitive and functional outcomes after liver transplant in children with early onset urea cycle disorders, maple syrup urine disease, and propionic acidemia: An inception cohort matched-comparison study. JIMD reports. 2020; 52:43-54.
Strauss KA, Williams KB, Carson VJ, Poskitt L, Bowser LE, Young M et al. Glutaric acidemia type 1: Treatment and outcome of 168 patients over three decades. Molecular Genetics and Metabolism. 2020; 131:325–340.
Foran J, Moore M, Crushell E, Knerr I, McSweeney N. Low excretor glutaric aciduria type 1 of insidious onset with dystonia and atypical clinical features, a diagnostic dilemma. JIMD reports. 2021; 58:12-20.
Zschocke J, Hoffmann GF. Vademecum Metabolicum Diagnosis and Treatment of Inherited Metabolic Disorders. 5th Edition. Stuttgart, Germany; Nutricia :2020.p 121.
Erçin S, Ovalı F. Yenidoğan Taramaları. Klinik Tıp Pediatri Dergisi.2019; 11(4):193-199.
